Literature DB >> 20682757

Frequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney disease.

Gul Sagun1, Gulcin Kantarci, Banu Mesci, Sinem Gungor, Funda Turkoglu, Elif Yorulmaz, Aytekin Oguz.   

Abstract

OBJECTIVE: Metabolic syndrome is a clustering of cardio-metabolic risk factors. Cardiovascular disease is the main cause of morbidity and mortality in end-stage renal disease. The aim of this study was to elucidate the frequency of traditional and novel cardiovascular and metabolic syndrome risk factors in patients with chronic kidney disease. Identification of these risk factors will allow for precautions to be taken earlier to prevent cardiovascular diseases and metabolic syndrome in chronic kidney disease patients.
METHODS: A total of 214 patients (91 females, 123 males, mean age 56.1 ± 14.4 years) with chronic kidney disease who were followed in the Nephrology Department of Istanbul Goztepe Training and Research Hospital were included in the study. Anthropometric and biochemical measurements for cardiovascular risk factors and metabolic syndrome parameters were recorded. Glomerular filtration rates (GFR) were estimated using the Cockroft Gault formula. Metabolic syndrome was defined according to International Diabetes Federation criteria.
RESULTS: Thirty-seven percent of patients with chronic renal failure were found to have three or more major cardiovascular risk factors. Seventy percent of patients were found to have metabolic syndrome. The mean numbers of major cardiovascular risk factors and metabolic syndrome parameters in patients with different GFR stages were: 1.8 ± 1.0, 2.6 ± 1.2 (GFR <15 mL/min per 1.73 m(2), n = 102); 2.4 ± 1.0, 3.0 ± 1.0 (GFR 15-29 mL/min per 1.73 m(2), n = 51 ); 2.5 ± 1.1, 3.3 ± 1.0 (GFR 30-59 mL/min per 1.73 m(2), n = 39); 2.4 ± 1.1, 3.5 ± 0.7 (GFR 60-89 mL/min per 1.73 m(2), n = 22), respectively (P = .001).
CONCLUSION: Although the frequency of cardiovascular risk factors and metabolic syndrome were high in patients with chronic kidney disease, they were negatively correlated with the stage of renal failure.

Entities:  

Mesh:

Year:  2010        PMID: 20682757      PMCID: PMC3006534          DOI: 10.3121/cmr.2010.892

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  33 in total

1.  Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.

Authors:  A P Guerin; J Blacher; B Pannier; S J Marchais; M E Safar; G M London
Journal:  Circulation       Date:  2001-02-20       Impact factor: 29.690

2.  Cardiovascular disease risk factors in chronic renal insufficiency.

Authors:  M J Sarnak; B E Coronado; T Greene; S R Wang; J W Kusek; G J Beck; A S Levey
Journal:  Clin Nephrol       Date:  2002-05       Impact factor: 0.975

3.  A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients.

Authors:  K Kalantar-Zadeh; J D Kopple; G Block; M H Humphreys
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

4.  Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?

Authors:  E H Fleischmann; J D Bower; A K Salahudeen
Journal:  Clin Nephrol       Date:  2001-09       Impact factor: 0.975

5.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.

Authors:  Manjula Kurella; Joan C Lo; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2005-05-18       Impact factor: 10.121

Review 6.  Atherogenic lipoproteins in end-stage renal disease.

Authors:  T Shoji; E Ishimura; M Inaba; T Tabata; Y Nishizawa
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

7.  Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994).

Authors:  J Coresh; G L Wei; G McQuillan; F L Brancati; A S Levey; C Jones; M J Klag
Journal:  Arch Intern Med       Date:  2001-05-14

8.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Authors:  Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

9.  Predialysis management and predictors for early mortality in uremic patients who die within one year after initiation of dialysis therapy.

Authors:  Georg Biesenbach; Rainer Hubmann; Othmar Janko; Bernhard Schmekal; Gabriela Eichbauer-Sturm
Journal:  Ren Fail       Date:  2002-03       Impact factor: 2.606

10.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.

Authors:  J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

View more
  1 in total

1.  The metabolic syndrome and severity of diabetic retinopathy.

Authors:  John J Chen; Lucas J Wendel; Emily S Birkholz; John G Vallone; Anne L Coleman; Fei Yu; Vinit B Mahajan
Journal:  Clin Ophthalmol       Date:  2015-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.